russia diagnostic imaging market outlook to 2020 · russia diagnostic imaging market outlook to...

Russia Diagnostic Imaging Market Outlook to 2020 GDMEMC0022DB / Published March 2014

© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form

Russia Diagnostic Imaging Market

Outlook to 2020

Reference Code: GDMEMC0022DB

Publication Date: March 2014



1 Table of Contents

1 Table of Contents .................................................................................................................................................... 2

1.1 List of Tables .................................................................................................................................................... 5

1.2 List of Figures ................................................................................................................................................... 9

2 Introduction ............................................................................................................................................................ 11

2.1 What Is This Report About? ........................................................................................................................... 11

2.2 Diagnostic Imaging Market Segmentation ..................................................................................................... 11

2.3 Definitions of Markets Covered in the Report ................................................................................................ 13

3 Diagnostic Imaging Market, Russia ..................................................................................................................... 19

3.1 Diagnostic Imaging Market, Russia, Revenue ($m), 2005-2020 ................................................................... 19

3.2 Diagnostic Imaging Market, Russia, Revenue Mix ($m), 2012 ...................................................................... 21

3.3 Diagnostic Imaging Market, Russia, Category Contribution by Revenue ($m), 2012 ................................... 22

3.4 Diagnostic Imaging Market, Russia, Category Comparison by Revenue ($m), 2005-2020 .......................... 24



3.7 Diagnostic Imaging Market, Russia, Volume (Units), 2005-2020 .................................................................. 30



3.10 Diagnostic Imaging Market, Russia, Company Share by Revenue ($m), 2011-2012 ................................... 36

4 Angio Suites Market, Russia ................................................................................................................................ 38

4.1 Angio Suites Market, Russia, Revenue ($m), 2005-2012 .............................................................................. 38

4.2 Angio Suites Market, Russia, Revenue ($m), 2012-2020 .............................................................................. 39

4.3 Angio Suites Market, Russia, Volume (Units), 2005-2012 ............................................................................. 40

4.4 Angio Suites Market, Russia, Volume (Units), 2012-2020 ............................................................................. 41

4.5 Angio Suites Market, Russia, Distribution Share by Revenue ($m), 2011-2012 ........................................... 42

4.6 Angio Suites Market, Russia, Company Share by Revenue ($m), 2011-2012 .............................................. 43

5 Bone Densitometers Market, Russia ................................................................................................................... 45

5.1 Bone Densitometers Market, Russia, Revenue ($m), 2005-2012 ................................................................. 45

5.2 Bone Densitometers Market, Russia, Revenue ($m), 2012-2020 ................................................................. 46

5.3 Bone Densitometers Market, Russia, Volume (Units), 2005-2012 ................................................................ 47

5.4 Bone Densitometers Market, Russia, Volume (Units), 2012-2020 ................................................................ 48

5.5 Bone Densitometers Market, Russia, Distribution Share by Revenue ($m), 2011-2012............................... 49

5.6 Bone Densitometers Market, Russia, Company Share by Revenue ($m), 2011-2012 ................................. 50

6 C-Arms Market, Russia ......................................................................................................................................... 52

6.1 C-Arms Market, Russia, Revenue ($m), 2005-2012 ...................................................................................... 52

6.2 C-Arms Market, Russia, Revenue ($m), 2012-2020 ...................................................................................... 53

6.3 C-Arms Market, Russia, Volume (Units), 2005-2012 ..................................................................................... 54

6.4 C-Arms Market, Russia, Volume (Units), 2012-2020 ..................................................................................... 55

6.5 C-Arms Market, Russia, Distribution Share by Revenue ($m), 2011-2012 ................................................... 56

6.6 C-Arms Market, Russia, Company Share by Revenue ($m), 2011-2012 ...................................................... 57



7 Computed Tomography Systems Market, Russia .............................................................................................. 59

7.1 Computed Tomography Systems Market, Russia, Revenue ($m), 2005-2012 ............................................. 59

7.2 Computed Tomography Systems Market, Russia, Revenue ($m), 2012-2020 ............................................. 61

7.3 Computed Tomography Systems Market, Russia, Volume (Units), 2005-2012 ............................................ 62

7.4 Computed Tomography Systems Market, Russia, Volume (Units), 2012-2020 ............................................ 63

7.5 Computed Tomography Systems Market, Russia, Distribution Share, Revenue ($m), 2011-2012 .............. 64

7.6 Computed Tomography Systems Market, Russia, Company Share by Revenue ($m), 2011-2012 ............. 65

8 Contrast Media Injectors Market, Russia ............................................................................................................ 67

8.1 Contrast Media Injectors Market, Russia, Revenue ($m), 2005-2012 ........................................................... 67

8.2 Contrast Media Injectors Market, Russia, Revenue ($m), 2012-2020 ........................................................... 69

8.3 Contrast Media Injectors Market, Russia, Volume (Units), 2005-2012 .......................................................... 70

8.4 Contrast Media Injectors Market, Russia, Volume (Units), 2012-2020 .......................................................... 71

8.5 Contrast Media Injectors Market, Russia, Distribution Share, Revenue ($m), 2011-2012 ............................ 72

8.6 Contrast Media Injectors Market, Russia, Company Share by Revenue ($m), 2011-2012 ........................... 73

9 Mammography Equipment Market, Russia ......................................................................................................... 75

9.1 Mammography Equipment Market, Russia, Revenue Mix ($m), 2012 .......................................................... 75

9.2 Mammography Equipment Market, Russia, Segment Contribution (%), 2012 .............................................. 76

9.3 Mammography Equipment Market, Russia, Revenue ($m), by Segment, 2005-2012 .................................. 77

9.4 Mammography Equipment Market, Russia, Revenue ($m) by Segment, 2012-2020 ................................... 79

9.5 Mammography Equipment Market, Russia, Volume (Units) by Segment, 2005-2012 .................................. 81

9.6 Mammography Equipment Market, Russia, Volume (Units) by Segment, 2012-2020 .................................. 83

9.7 Mammography Equipment Market, Russia, Distribution Share, Revenue ($m), 2011-2012 ......................... 85

9.8 Mammography Equipment Market, Russia, Company Share by Revenue ($m), 2011-2012........................ 86

10 MRI Systems Market, Russia ............................................................................................................................. 88

10.1 MRI Systems Market, Russia, Revenue ($m), 2005-2012............................................................................. 88

10.2 MRI Systems Market, Russia, Revenue ($m), 2012-2020............................................................................. 90

10.3 MRI Systems Market, Russia, Volume (Units), 2005-2012............................................................................ 91

10.4 MRI Systems Market, Russia, Volume (Units), 2012-2020............................................................................ 92

10.5 MRI Systems Market, Russia, Distribution Share, Revenue ($m), 2011-2012 .............................................. 93

10.6 MRI Systems Market, Russia, Company Share by Revenue ($m), 2011-2012 ............................................ 94

11 Nuclear Imaging Equipment Market, Russia ................................................................................................... 96

11.1 Nuclear Imaging Equipment Market, Russia, Revenue Mix ($m), 2012 ........................................................ 96

11.2 Nuclear Imaging Equipment Market, Russia, Segment Contribution (%), 2012 ............................................ 97

11.3 Nuclear Imaging Equipment Market, Russia, Revenue ($m), by Segment, 2005-2012 ................................ 98

11.4 Nuclear Imaging Equipment Market, Russia, Revenue ($m) by Segment, 2012-2020 ............................... 100

11.5 Nuclear Imaging Equipment Market, Russia, Volume (Units) by Segment, 2005-2012 .............................. 102

11.6 Nuclear Imaging Equipment Market, Russia, Volume (Units) by Segment, 2012-2020 .............................. 104

11.7 Nuclear Imaging Equipment Market, Russia, Distribution Share, Revenue ($m), 2011-2012..................... 106

11.8 Nuclear Imaging Equipment Market, Russia, Company Share by Revenue ($m), 2011-2012 ................... 107

12 Ultrasound Systems Market, Russia .............................................................................................................. 109

12.1 Ultrasound Systems Market, Russia, Revenue Mix ($m), 2012 .................................................................. 109



12.2 Ultrasound Systems Market, Russia, Segment Contribution (%), 2012 ...................................................... 110

12.3 Ultrasound Systems Market, Russia, Revenue ($m), by Segment, 2005-2012 .......................................... 111

12.4 Ultrasound Systems Market, Russia, Revenue ($m) by Segment, 2012-2020 ........................................... 113

12.5 Ultrasound Systems Market, Russia, Volume (Units) by Segment, 2005-2012 .......................................... 115

12.6 Ultrasound Systems Market, Russia, Volume (Units) by Segment, 2012-2020 .......................................... 117

12.7 Ultrasound Systems Market, Russia, Distribution Share, Revenue ($m), 2011-2012 ................................. 119

12.8 Ultrasound Systems Market, Russia, Company Share by Revenue ($m), 2011-2012 ................................ 120

13 X-ray Systems Market, Russia ........................................................................................................................ 122

13.1 X-ray Systems Market, Russia, Revenue Mix ($m), 2012 ........................................................................... 122

13.2 X-ray Systems Market, Russia, Segment Contribution (%), 2012 ............................................................... 123

13.3 X-ray Systems Market, Russia, Revenue ($m), by Segment, 2005-2012 ................................................... 124

13.4 X-ray Systems Market, Russia, Revenue ($m) by Segment, 2012-2020 .................................................... 126

13.5 X-ray Systems Market, Russia, Volume (Units) by Segment, 2005-2012 ................................................... 128

13.6 X-ray Systems Market, Russia, Volume (Units) by Segment, 2012-2020 ................................................... 130

13.7 X-ray Systems Market, Russia, Distribution Share, Revenue ($m), 2011-2012 .......................................... 132

13.8 X-ray Systems Market, Russia, Company Share by Revenue ($m), 2011-2012 ........................................ 133

14 Overview of Key Companies in Russia, Diagnostic Imaging Market .......................................................... 135

14.1 GE Healthcare .............................................................................................................................................. 135

14.1.1 Company Overview .............................................................................................................................. 135

14.2 Siemens Healthcare ..................................................................................................................................... 135


14.3 Philips Healthcare ........................................................................................................................................ 135


14.4 Toshiba Medical Systems Corporation ........................................................................................................ 136


14.5 Medical Technologies Ltd. ........................................................................................................................... 136


14.6 AMICO .......................................................................................................................................................... 136


14.7 ELECTRON Ltd. ........................................................................................................................................... 137


14.8 Hitachi Medical Corporation ......................................................................................................................... 137


14.9 Esaote S.p.A. ............................................................................................................................................... 137


15 Diagnostic Imaging Market Pipeline Products .............................................................................................. 138

16 Financial Deals Landscape ............................................................................................................................. 142

16.1 Asset Transactions ....................................................................................................................................... 142

16.1.1 Threshold Pharma To Acquire Hypoxia PET Imaging Agent 18F-HX4 From Siemens Healthcare .... 142

16.2 Partnerships ................................................................................................................................................. 144

16.2.1 Bracco Imaging Enters Into Co-Marketing Agreement With PHS Technologies For DoseMonitor ..... 144



16.2.2 Imaging Dynamics To Enter Into Co-Marketing Agreement With Kangda Medical ............................. 145

16.2.3 Positron Enters Into Licensing Agreement With Institute for Nuclear Research For Radiostrontium Production Technology .......................................................................................................................................... 146

16.2.4 Digirad Enters Into Distribution Agreement With Dilon Diagnostics .................................................... 148

16.2.5 Centre For Imaging Technology Enters Into Agreement With Western University And Claron Technology For Oncology Therapy ....................................................................................................................... 149

16.2.6 Bluechiip Enters Into Distribution Agreement With Mitegen ................................................................ 150

16.2.7 GE Healthcare And Konica Minolta Enter Into Global Distribution Agreement For AeroDR ............... 151

16.2.8 Ventana Medical And Barco Enter Into Agreement For Digital Pathology Imaging Platform .............. 152

16.2.9 MiTeGen Enters Into Development And Distribution Agreement With EMBL Enterprise .................... 154

16.2.10 Invivo Enters Into Co-Development Agreement With iCAD For MRI Solutions ................................... 155

16.2.11 Bayer HealthCare Enters Into Distribution Agreement With Comecer For Medrad Intego PET Infusion System 156

16.2.12 ImaginAb Exercises Option For Licensing Agreement With Oxford BioMedica To License Vivo 5T4-Based Imaging Diagnostic ..................................................................................................................................... 157

16.2.13 GE Healthcare Enters Into Agreement With Core Sound Imaging To Distribute Studycast ................ 158

16.2.14 Bayer HealthCare Enters Into Agreement With Medsintez .................................................................. 159

16.2.15 IBA Molecular Enters Into Distribution Agreement With Piramal Imaging For 18F-Florbetaben ......... 160

16.2.16 Actuated Medical Enters Into Co-Marketing Agreement With Kimal For TubeClear System .............. 161

16.2.17 Olympus Europa Holding Enters Into Distribution Agreement With Applied Spectral Imaging For GenASIs 162

16.2.18 Varian Medical Systems Enters Into Co-Marketing Agreement With Siemens Healthcare ................. 163

16.2.19 GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System ....................................................................................................................................................... 165

16.2.20 Almaz-Antey Enters Into Joint Venture Agreement With Electron To Form Antey-Med ..................... 166

17 Recent Developments ...................................................................................................................................... 167

17.1 Strategy And Business Planning .................................................................................................................. 167

17.1.1 Sep 05, 2013: Bayer plans further expansion in Russia ...................................................................... 167

18 Appendix ........................................................................................................................................................... 169

18.1 Research Methodology ................................................................................................................................ 170

18.1.1 Coverage .............................................................................................................................................. 170

18.1.2 Secondary Research ............................................................................................................................ 170

18.1.3 Primary Research ................................................................................................................................. 171

18.1.4 Market Modeling and Forecasting ........................................................................................................ 172

18.1.5 Company Share Analysis ..................................................................................................................... 175

18.1.6 Distribution Share Analysis .................................................................................................................. 176

18.2 Expert Panel ................................................................................................................................................. 176

18.3 GlobalData Consulting ................................................................................................................................. 177

18.4 Disclaimer ..................................................................................................................................................... 177

1.1 List of Tables

Table 1: Diagnostic Imaging Market, Russia, Revenue ($m), USD Constant, 2005-2020 .............................................................. 20



Table 2: Diagnostic Imaging Market, Russia, Category Contribution by Revenue ($m), 2012 ....................................................... 23

Table 3: Diagnostic Imaging Market, Russia, Category Comparison by Revenue ($m), 2005-2020 .............................................. 25

Table 4: Diagnostic Imaging Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ................................................ 27

Table 5: Diagnostic Imaging Market, Russia, Revenue ($m), USD Constant, Forecast, 2012-2020 .............................................. 29

Table 6: Diagnostic Imaging Market, Russia, Volume (Units), 2005-2020...................................................................................... 31

Table 7: Diagnostic Imaging Market, Russia, Volume (Units), Historic, 2005-2012 ........................................................................ 33

Table 8: Diagnostic Imaging Market, Russia, Volume (Units), Forecast, 2012-2020 ...................................................................... 35

Table 9: Diagnostic Imaging Market, Russia, Company Share by Revenue ($m), USD Constant, 2011-2012 .............................. 37

Table 10: Angio Suites Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ........................................................ 38

Table 11: Angio Suites Market, Russia, Revenue ($m), USD Constant, Forecast, 2012-2020 ...................................................... 39

Table 12: Angio Suites Market, Russia, Volume (Units), Historic, 2005-2012 ................................................................................ 40

Table 13: Angio Suites Market, Russia, Volume (Units), Forecast, 2012-2020 .............................................................................. 41

Table 14: Angio Suites Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 .................................... 42

Table 15: Angio Suites Market, Russia, Company Share by Revenue ($m), USD Constant, 2011-2012 ...................................... 44

Table 16: Bone Densitometers Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ............................................ 45

Table 17: Bone Densitometers Market, Russia, Revenue ($m), USD Constant, Forecast, 2012-2020 .......................................... 46

Table 18: Bone Densitometers Market, Russia, Volume (Units), Historic, 2005-2012 .................................................................... 47

Table 19: Bone Densitometers Market, Russia, Volume (Units), Forecast, 2012-2020 .................................................................. 48

Table 20: Bone Densitometers Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ........................ 49

Table 21: Bone Densitometers Market, Russia, Company Share by Revenue ($m), USD Constant, 2011-2012 .......................... 51

Table 22: C-Arms Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ................................................................ 52

Table 23: C-Arms Market, Russia, Revenue ($m), USD Constant, Forecast, 2012-2020 .............................................................. 53

Table 24: C-Arms Market, Russia, Volume (Units), Historic, 2005-2012 ........................................................................................ 54

Table 25: C-Arms Market, Russia, Volume (Units), Forecast, 2012-2020 ...................................................................................... 55

Table 26: C-Arms Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ............................................ 56

Table 27: C-Arms Market, Russia, Company Share by Revenue ($m), USD Constant, 2011-2012 .............................................. 58

Table 28: Computed Tomography Systems Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ........................ 60

Table 29: Computed Tomography Systems Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 ....................... 61

Table 30: Computed Tomography Systems Market, Russia, Volume (Units), Historic, 2005-2012 ................................................ 62

Table 31: Computed Tomography Systems Market, Russia, Volume (Units), Forecast, 2012-2020 .............................................. 63

Table 32: Computed Tomography Systems Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 .... 64

Table 33: Computed Tomography Systems Market, Russia, Company Share by Revenue ($m), USD Constant, 2011-2012 ...... 66

Table 34: Contrast Media Injectors Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ..................................... 68

Table 35: Contrast Media Injectors Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 .................................... 69

Table 36: Contrast Media Injectors Market, Russia, Volume (Units), Historic, 2005-2012 ............................................................. 70

Table 37: Contrast Media Injectors Market, Russia, Volume (Units), Forecast, 2012-2020 ........................................................... 71

Table 38: Contrast Media Injectors Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ................. 72

Table 39: Contrast Media Injectors Market, Russia, Company Share by Revenue ($m), USD Constant, 2011-2012 .................... 74

Table 40: Mammography Equipment Market, Russia, Segment Contribution (%), 2012 ................................................................ 76

Table 41: Mammography Equipment Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 .................................. 78

Table 42: Mammography Equipment Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 ................................. 80

Table 43: Mammography Equipment Market, Russia, Volume (Units), Historic, 2005-2012 .......................................................... 82

Table 44: Mammography Equipment Market, Russia, Volume (Units), Forecast, 2012-2020 ........................................................ 84



Table 45: Mammography Equipment Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 .............. 85

Table 46: Mammography Equipment Market, Russia, Company Share by Revenue ($m), USD Constant, 2011-2012 ................. 87

Table 47: MRI Systems Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ....................................................... 89

Table 48: MRI Systems Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 ...................................................... 90

Table 49: MRI Systems Market, Russia, Volume (Units), Historic, 2005-2012 ............................................................................... 91

Table 50: MRI Systems Market, Russia, Volume (Units), Forecast, 2012-2020 ............................................................................. 92

Table 51: MRI Systems Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ................................... 93

Table 52: MRI Systems Market, Russia, Company Share by Revenue ($m), USD Constant, 2011-2012 ..................................... 95

Table 53: Nuclear Imaging Equipment Market, Russia, Segment Contribution (%), 2012 ............................................................. 97

Table 54: Nuclear Imaging Equipment Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ................................ 99

Table 55: Nuclear Imaging Equipment Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 ............................. 101

Table 56: Nuclear Imaging Equipment Market, Russia, Volume (Units), Historic, 2005-2012 ...................................................... 103

Table 57: Nuclear Imaging Equipment Market, Russia, Volume (Units), Forecast, 2012-2020 .................................................... 105

Table 58: Nuclear Imaging Equipment Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 .......... 106

Table 59: Nuclear Imaging Equipment Market, Russia, Company Share by Revenue ($m), USD Constant, 2011-2012 ............ 108

Table 60: Ultrasound Systems Market, Russia, Segment Contribution (%), 2012 ........................................................................ 110

Table 61: Ultrasound Systems Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 .......................................... 112

Table 62: Ultrasound Systems Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 ......................................... 114

Table 63: Ultrasound Systems Market, Russia, Volume (Units), Historic, 2005-2012 .................................................................. 116

Table 64: Ultrasound Systems Market, Russia, Volume (Units), Forecast, 2012-2020 ................................................................ 118

Table 65: Ultrasound Systems Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ...................... 119

Table 66: Ultrasound Systems Market, Russia, Company Share by Revenue ($m), USD Constant, 2011-2012 ......................... 121

Table 67: X-ray Systems Market, Russia, Segment Contribution (%), 2012 ................................................................................ 123

Table 68: X-ray Systems Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ................................................... 125

Table 69: X-ray Systems Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 .................................................. 127

Table 70: X-ray Systems Market, Russia, Volume (Units), Historic, 2005-2012 ........................................................................... 129

Table 71: X-ray Systems Market, Russia, Volume (Units), Forecast, 2012-2020 ......................................................................... 131

Table 72: X-ray Systems Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2011-2012 ............................... 132

Table 73: X-ray Systems Market, Russia, Company Share by Revenue ($m), USD Constant, 2011-2012 ................................. 134

Table 74: Diagnostic Imaging Market Pipeline Products .............................................................................................................. 138

Table 75: Threshold Pharma To Acquire Hypoxia PET Imaging Agent 18F-HX4 From Siemens Healthcare .............................. 142

Table 76: Bracco Imaging Enters Into Co-Marketing Agreement With PHS Technologies For DoseMonitor ............................... 144

Table 77: Imaging Dynamics To Enter Into Co-Marketing Agreement With Kangda Medical ....................................................... 145

Table 78: Positron Enters Into Licensing Agreement With Institute for Nuclear Research For Radiostrontium Production

Technology ..................................................................................................................................................................................... 146

Table 79: Digirad Enters Into Distribution Agreement With Dilon Diagnostics .............................................................................. 148

Table 80: Centre For Imaging Technology Enters Into Agreement With Western University And Claron Technology For Oncology

Therapy .......................................................................................................................................................................................... 149

Table 81: Bluechiip Enters Into Distribution Agreement With Mitegen ......................................................................................... 150

Table 82: GE Healthcare And Konica Minolta Enter Into Global Distribution Agreement For AeroDR ......................................... 151

Table 83: Ventana Medical And Barco Enter Into Agreement For Digital Pathology Imaging Platform ........................................ 152

Table 84: MiTeGen Enters Into Development And Distribution Agreement With EMBL Enterprise .............................................. 154

Table 85: Invivo Enters Into Co-Development Agreement With iCAD For MRI Solutions ............................................................ 155



Table 86: Bayer HealthCare Enters Into Distribution Agreement With Comecer For Medrad Intego PET Infusion System ......... 156

Table 87: ImaginAb Exercises Option For Licensing Agreement With Oxford BioMedica To License Vivo 5T4-Based Imaging

Diagnostic ....................................................................................................................................................................................... 157

Table 88: GE Healthcare Enters Into Agreement With Core Sound Imaging To Distribute Studycast ......................................... 158

Table 89: Bayer HealthCare Enters Into Agreement With Medsintez ........................................................................................... 159

Table 90: IBA Molecular Enters Into Distribution Agreement With Piramal Imaging For 18F-Florbetaben ................................... 160

Table 91: Actuated Medical Enters Into Co-Marketing Agreement With Kimal For TubeClear System ........................................ 161

Table 92: Olympus Europa Holding Enters Into Distribution Agreement With Applied Spectral Imaging For GenASIs ................ 162

Table 93: Varian Medical Systems Enters Into Co-Marketing Agreement With Siemens Healthcare ........................................... 163

Table 94: GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System

....................................................................................................................................................................................................... 165

Table 95: Almaz-Antey Enters Into Joint Venture Agreement With Electron To Form Antey-Med .............................................. 166

Table 96: Total Number of Primary Research Participants, Diagnostic Imaging Equipment Market, by Country ......................... 172



1.2 List of Figures

Figure 1: Diagnostic Imaging Market, Russia, Revenue ($m), USD Constant, 2005-2020............................................................. 19

Figure 2: Diagnostic Imaging Market, Russia, Revenue Mix ($m), 2012 ........................................................................................ 21

Figure 3: Diagnostic Imaging Market, Russia, Category Contribution (%), 2012 ............................................................................ 22

Figure 4: Diagnostic Imaging Market, Russia, Category Comparison by Revenue ($m), 2005-2020 ............................................. 24

Figure 5: Diagnostic Imaging Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ............................................... 26

Figure 6: Diagnostic Imaging Market, Russia, Revenue ($m), USD Constant, Forecast, 2012-2020 ............................................. 28

Figure 7: Diagnostic Imaging Market, Russia, Volume (Units), 2005-2020 .................................................................................... 30

Figure 8: Diagnostic Imaging Market, Russia, Volume (Units), Historic, 2005-2012 ...................................................................... 32

Figure 9: Diagnostic Imaging Market, Russia, Volume (Units), Forecast, 2012-2020 .................................................................... 34

Figure 10: Diagnostic Imaging Market, Russia, Company Share (%), 2012 ................................................................................... 36

Figure 11: Angio Suites Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ....................................................... 38

Figure 12: Angio Suites Market, Russia, Revenue ($m), USD Constant, Forecast, 2012-2020 ..................................................... 39

Figure 13: Angio Suites Market, Russia, Volume (Units), Historic, 2005-2012 ............................................................................... 40

Figure 14: Angio Suites Market, Russia, Volume (Units), Forecast, 2012-2020 ............................................................................. 41

Figure 15: Angio Suites Market, Russia, Company Share (%), 2012 ............................................................................................. 43

Figure 16: Bone Densitometers Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ........................................... 45

Figure 17: Bone Densitometers Market, Russia, Revenue ($m), USD Constant, Forecast, 2012-2020 ......................................... 46

Figure 18: Bone Densitometers Market, Russia, Volume (Units), Historic, 2005-2012 .................................................................. 47

Figure 19: Bone Densitometers Market, Russia, Volume (Units), Forecast, 2012-2020 ................................................................ 48

Figure 20: Bone Densitometers Market, Russia, Company Share (%), 2012 ................................................................................. 50

Figure 21: C-Arms Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ............................................................... 52

Figure 22: C-Arms Market, Russia, Revenue ($m), USD Constant, Forecast, 2012-2020 ............................................................. 53

Figure 23: C-Arms Market, Russia, Volume (Units), Historic, 2005-2012 ....................................................................................... 54

Figure 24: C-Arms Market, Russia, Volume (Units), Forecast, 2012-2020 ..................................................................................... 55

Figure 25: C-Arms Market, Russia, Company Share (%), 2012 ..................................................................................................... 57

Figure 26: Computed Tomography Systems Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ....................... 59

Figure 27: Computed Tomography Systems Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 ...................... 61

Figure 28: Computed Tomography Systems Market, Russia, Volume (Units), Historic, 2005-2012 ............................................... 62

Figure 29: Computed Tomography Systems Market, Russia, Volume (Units), Forecast, 2012-2020 ............................................. 63

Figure 30: Computed Tomography Systems Market, Russia, Company Share (%), 2012 ............................................................. 65

Figure 31: Contrast Media Injectors Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 .................................... 67

Figure 32: Contrast Media Injectors Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 ................................... 69

Figure 33: Contrast Media Injectors Market, Russia, Volume (Units), Historic, 2005-2012 ............................................................ 70

Figure 34: Contrast Media Injectors Market, Russia, Volume (Units), Forecast, 2012-2020 .......................................................... 71

Figure 35: Contrast Media Injectors Market, Russia, Company Share (%), 2012 .......................................................................... 73

Figure 36: Mammography Equipment Market, Russia, Revenue Mix ($m), 2012 .......................................................................... 75

Figure 37: Mammography Equipment Market, Russia, Segment Contribution (%), 2012 .............................................................. 76

Figure 38: Mammography Equipment Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ................................. 77

Figure 39: Mammography Equipment Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 ................................ 79

Figure 40: Mammography Equipment Market, Russia, Volume (Units), Historic, 2005-2012 ......................................................... 81

Figure 41: Mammography Equipment Market, Russia, Volume (Units), Forecast, 2012-2020 ....................................................... 83



Figure 42: Mammography Equipment Market, Russia, Company Share (%), 2012 ....................................................................... 86

Figure 43: MRI Systems Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ...................................................... 88

Figure 44: MRI Systems Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 ..................................................... 90

Figure 45: MRI Systems Market, Russia, Volume (Units), Historic, 2005-2012 .............................................................................. 91

Figure 46: MRI Systems Market, Russia, Volume (Units), Forecast, 2012-2020 ............................................................................ 92

Figure 47: MRI Systems Market, Russia, Company Share (%), 2012 ............................................................................................ 94

Figure 48: Nuclear Imaging Equipment Market, Russia, Revenue Mix ($m), 2012 ........................................................................ 96

Figure 49: Nuclear Imaging Equipment Market, Russia, Segment Contribution (%), 2012 ............................................................ 97

Figure 50: Nuclear Imaging Equipment Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ............................... 98

Figure 51: Nuclear Imaging Equipment Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 ............................ 100

Figure 52: Nuclear Imaging Equipment Market, Russia, Volume (Units), Historic, 2005-2012 ..................................................... 102

Figure 53: Nuclear Imaging Equipment Market, Russia, Volume (Units), Forecast, 2012-2020 ................................................... 104

Figure 54: Nuclear Imaging Equipment Market, Russia, Company Share (%), 2012 ................................................................... 107

Figure 55: Ultrasound Systems Market, Russia, Revenue Mix ($m), 2012 .................................................................................. 109

Figure 56: Ultrasound Systems Market, Russia, Segment Contribution (%), 2012 ...................................................................... 110

Figure 57: Ultrasound Systems Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 ......................................... 111

Figure 58: Ultrasound Systems Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 ........................................ 113

Figure 59: Ultrasound Systems Market, Russia, Volume (Units), Historic, 2005-2012 ................................................................. 115

Figure 60: Ultrasound Systems Market, Russia, Volume (Units), Forecast, 2012-2020 ............................................................... 117

Figure 61: Ultrasound Systems Market, Russia, Company Share (%), 2012 ............................................................................... 120

Figure 62: X-ray Systems Market, Russia, Revenue Mix ($m), 2012 ........................................................................................... 122

Figure 63: X-ray Systems Market, Russia, Segment Contribution (%), 2012 ............................................................................... 123

Figure 64: X-ray Systems Market, Russia, Revenue ($m), USD Constant, Historic, 2005-2012 .................................................. 124

Figure 65: X-ray Systems Market, Russia, Revenue ($m) USD Constant, Forecast, 2012-2020 ................................................. 126

Figure 66: X-ray Systems Market, Russia, Volume (Units), Historic, 2005-2012 .......................................................................... 128

Figure 67: X-ray Systems Market, Russia, Volume (Units), Forecast, 2012-2020 ........................................................................ 130

Figure 68: X-ray Systems Market, Russia, Company Share (%), 2012 ........................................................................................ 133

Figure 69: GlobalData Epidemiology-Based Forecasting Model .................................................................................................. 174

Figure 70: GlobalData Capital Equipment-Based Forecasting Model .......................................................................................... 175

Figure 71: Primary Interviews by Participant Type (%) ................................................................................................................. 176



2 Introduction

Medical Equipment Market Reports are the ideal guide for anyone wishing to understand their market better in terms

of revenues, unit sales, distributors and competitors.

2.1 What Is This Report About?

This report provides an overview and the following information related to the country, various categories, distribution

share and competitive landscape in the market:

1. Comprehensive data related to the market revenue, unit sale, company share and distribution share.

2. Corporate-level profiles of key companies operating in the Diagnostic Imaging market, which includes a

brief overview of the company. The selection of the companies is based on their operational presence.

3. A list of key products under development by different companies. The selection of this list is based on the

territory in which these products are being clinically investigated.

4. Key news and deals related to the Diagnostic Imaging market.

2.2 Diagnostic Imaging Market Segmentation

Diagnostic Imaging market is segmented into the following categories, as described below, in this report:

1. Angio Suites

2. Bone Densitometers

3. C-Arms

4. Computed Tomography (CT) Systems includes segments such as

High Slice CT Systems

Low Slice CT Systems

Mid Slice CT Systems

5. Contrast Media Injectors includes segments such as

CT Injectors

Interventional Cardiology/Angio Injectors

MRI Injectors

6. Mammography Equipment includes segments such as

Film-Screen Mammography Equipment

Full-Field Digital Mammography Equipment

• Full-Field Digital Mammography Equipment includes sub-segments such as 2D Digital

Mammography Equipment and 3D Tomosynthesis

7. Magnetic Resonance Imaging (MRI) Systems includes segments such as

High Field MRI Systems

Low Field MRI Systems

Mid Field MRI Systems



8. Nuclear Imaging Equipment includes segments such as

Positron Emission Tomography (PET) Systems

• Positron Emission Tomography Systems includes sub-segments such as PET Systems, PET/CT

and PET/MRI Systems

Single Photon Emission Computed Tomography (SPECT) Systems

• Single Photon Emission Computed Tomography Systems includes sub-segments such as SPECT

and SPECT/CT Systems

9. Ultrasound Systems includes segments such as

B/W Ultrasound Systems

• B/W Ultrasound Systems includes sub-segments such as Portable B/W Ultrasound Systems and

Stand Alone B/W Ultrasound Systems

Color Ultrasound Systems

• Color Ultrasound Systems includes sub-segments such as Portable Color Ultrasound Systems and

Stand Alone Color Ultrasound Systems

10. X-ray Systems includes segments such as

Analog X-ray Systems

Digital X-ray Systems

• Digital X-ray Systems includes sub-segments such as Computed Radiography (CR) Systems and

Digital Radiography (DR) Systems

Retrofit X-ray Systems



2.3 Definitions of Markets Covered in the Report

Diagnostic Imaging

Diagnostic imaging devices are used for the visualization of structural and functional patterns of organs or tissues. MRI systems,

Ultrasound Systems, X-ray systems, Bone Densitometers, C-Arms, Angio Suites, Mammography Equipments, Computed

Tomography System, Nuclear Imaging Equipments and Contrast Media Injectors are tracked under this market.

Angio Suites

Angio Suites are multi-purpose examination rooms, where diverse angio/interventional procedures are performed. Procedures

performed in these include angioplasty, therapeutic stenting, obstruction bypasses, intravascular therapy, angiograms, mylograms,

vertebroplasty and surgery-free removal of tissue specimens. A typical Angio-Suite includes: X-ray generator, image intensifier

(mostly C-arms) and a rotating table top for easy patient positioning and movement. One unit is defined as one system.

Bone Densitometers

Bone densitometers are devices used to measure bone mineral density with techniques such as Dual-Energy X-ray

Absorptiometry (DEXA), Quantitative Computed Tomography (QCT), Radiographic Absorptiometry (RA) and Quantitative

Ultrasound (QU). In the report, only DEXA bone densitometers have been tracked. One unit is defined as one system..

C-Arms

C-Arms are imaging scanner intensifier primarily used for the fluoroscopic imaging during surgical, orthopedic, critical care, and

emergency care procedures. In the report, only mobile C-arms have been tracked. One unit is defined as one device.

Computed Tomography (CT) Systems

Computed tomography is a powerful, non-destructive evaluation technique used for producing 2D and 3D cross-sectional image of

an object from a flat X-ray image. It is used on patients with a high risk of colon cancer, or full-motion heart scans for patients with

high risk of heart disease. It can also be used for image complex fractures, detect infarction, tumors, calcifications, hemorrhage

and bone trauma and also acute and chronic changes in the lung parenchyma etc. The device includes a slice detector and an X-

ray source. High, mid and low slice computed tomography systems have been included in this category. Tracked hereunder are

the equipment only and not accessories and/or additional costs associated with CT installation.

High Slice Computed Tomography Systems

High-Slice computed tomography segment includes CT systems which are 128 slice and above. One unit is defined as one

system.

Mid Slice Computed Tomography Systems

Mid-Slice computed tomography segment includes CT systems which are above 16 slice and below 128 slice. One unit is defined

as one system.



Low Slice Computed Tomography Systems

Low-Slice computed tomography segment includes CT systems which are 16 slice and below. One unit is defined as one system.

Contrast Media Injectors

Contrast Media Injectors are devices used to inject contrast media agents into the bloodstream of patients, to enable visualization

of various pathologies through X-ray, computed tomography, magnetic resonance, or other medical imaging devices. CT Injectors,

MRI Injectors and Interventional/Angio Injectors have been included in this category.

CT Injectors

CT Injectors are devices used in conjunction with CT systems to inject contrast media agents into the blood stream of patients. A

unit refers to a floor mounted or roof mounted power injector and a computerized control unit.

Interventional Cardiology/Angio Injectors

Interventional Cardiology/ Angio Injectors are devices used during cardiac and vascular angiographic procedures to inject contrast

media agents into the blood stream of patients. A unit refers to a floor mounted or roof mounted power injector and a computerized

control unit.

MRI Injectors

MRI Injectors are devices used in conjunction with MRI systems to inject contrast media agents into the blood stream of patients. A

unit refers to a floor mounted or roof mounted power injector and a computerized control unit.

Mammography Equipment

Mammography is a type of medical imaging that uses X-rays to capture images (mammograms) of the internal structures of the

breasts. Mammography plays a key role in early diagnosis of breast cancer. Film-screen mammography equipment and full-field

digital mammography equipment have been included in this market. Tracked hereunder are the equipment only and not

accessories and/or additional costs associated with Mammography equipment installation.

Film-Screen Mammography Equipment

Film-screen mammography unit consists of an X-ray generator, X-ray source assembly, collimator, compression device, breast

support, grid assemblies and automatic exposure control subsystem. Film screen mammography or analog mammography is a

specific type of imaging that uses a low-dose X-ray system to examine breasts. One unit is defined as one film-screen

mammography equipment.

Full-Field Digital Mammography Equipment

Full Field digital mammography system is a mammography system in which the X-ray film is replaced by solid-state detectors that

convert X-rays into electrical signals. One unit is defined as one full Field digital mammography system.



2D Digital Mammography Equipment

In 2D Digital Mammography Equipment, X-ray beams are captured on the digital camera and images are produced by the

computer, and that images are sent electronically to the radiologists to view.

3D Tomosynthesis

3D Tomosynthesis is a system in which the imaging machines moves around the breast in an arc, and taking multiple X-ray that

computer forms in to 3D images.

MRI Systems

Magnetic Resonance Imaging (MRI) utilizes radiofrequency and a strong magnetic field to generate clear and detailed images of

internal organs and tissues. MRI is generally preferred for the diagnosis of brain and other neurological disorders. High field (3T),

Mid field (1.5T) and Low field (less than 1.5T) MRI systems have been tracked under this category. Tracked here under are the

equipment only and not accessories and/or additional costs associated with MRI system installation.

High Field MRI Systems

MRI systems with greater than or equal to 3 Tesla in field strength is included in this segment. One unit is defined as one high field

MRI system.

Mid Field MRI Systems

MRI systems with 1.5 Tesla in field strength are included in this segment. One unit is defined as one mid filed MRI system.

Low Field MRI Systems

MRI systems with less than 1.5 Tesla in field strength are included in this segment. One unit is defined as one low field MRI

system.

Nuclear Imaging Equipment

Nuclear imaging equipment are used to produce images by detecting radiation from different parts of the body after a radioactive

tracer material is administered. It helps in imaging various disease areas as presence or spread of cancer in various parts of the

body, myocardial perfusion scan, kidney function analysis, thyroid function to detect an overactive or underactive thyroid, localize

the lymph nodes before surgery, investigate abnormalities in the brain, such as seizures, memory loss and abnormalities in blood

flow etc. Positron emission tomography, single photon emission computed tomography have been tracked under this category.

Tracked hereunder are the equipment only and not accessories and/or additional costs associated with nuclear Imaging equipment

installation.



Positron Emission Tomography Systems

Positron emission tomography (PET) systems are non-invasive diagnostic imaging procedures that assess the level of metabolic

activity and perfusion in various organ systems of the human body, obtained from positron emitting radioactive tracer substances

that are administered intravenously. It helps in identifying abnormalities or functioning of the intestinal tract or brain etc.

Conventional PET and PET/CT or a hybrid PET coupled with the capabilities of a Computed Tomography (CT) have been included

under this category.

PET Systems

Positron emission tomography systems are used to produce tomographic images by detecting the location and distribution of

positron-emitting radionuclides in the body. The device consists of a detector, gantry system, patients table and a transmission

source. One unit is defined as one PET system.

PET/CT Systems

A PET/CT system combines the images from PET with the anatomical data of a Computed Tomography (CT) scan to produce

single superimposed image. PET/CT provides superior information for determining tissue characterizations and classifications,

staging of cancers, restaging of cancers, patient prognosis and monitoring the effectiveness of cancer therapies. It provides

superior lesion localization from near-perfect anatomical/functional registration with fewer motion artifacts. It uses shorter scan

time (avg. 30 minutes to complete, vs. 60 minutes with standard PET). The device consists of a detector, gantry system,

transmission source, computer workstation and software. One unit is defined as one PET/CT system.

PET/MRI Systems

A PET/MRI system combines the functional information in regard to the metabolism or physiology, obtained from a PET scan, with

morphological and anatomical imaging of soft tissues, obtained from a MRI scan. PET/MRI is primarily used in functional

assessment of cancer, especially cancers of head, neck, brain and prostate. One unit is defined as one PET/MRI system.

Single Photon Emission Computed Tomography Systems

Single photon emission computed tomography (SPECT) is a nuclear medicine technique that uses radiopharmaceuticals, a

rotating camera (single or multiple-head), and a computer to produce images representing slices through the body in different

planes. The SPECT systems can be a conventional SPECT or a hybrid SPECT coupled with the capabilities of a computed

tomography. SPECT permits accurate localization in 3D space and can be helpful for tumor imaging, infection (leukocyte) imaging,

thyroid imaging or bone imaging conventional SPECT and hybrid SPECT coupled with the capabilities of a Computed Tomography

(CT) have been tracked .

SPECT Systems

Single photon emission computed tomography (SPECT) is used to construct images of the distribution of the radioactive tracers in

the human body by measuring the emission of single photons of a given energy from radioactive tracers. The device includes a

detector, gantry system, patient’s table and collimators. One unit is defined as one SPECT system.



SPECT/CT Systems

A SPECT/CT system is a technically advanced tomography system which combines the SPECT information with the anatomical

data of a Computed Tomography (CT) scan to provide more information about the body. SPECT/CT is primarily used for

cardiology applications, such as calcium scoring and computed tomography angiography (CTA). SPECT/CT is being utilized in the

three emerging areas of orthopedics and sports-related medicine, oncology and infection imaging. The device includes a detector,

gantry system, patient’s table, collimators, image acquisition, process workstation and software. One unit is defined as one

SPECT/CT system.

Ultrasound Systems

Ultrasound imaging systems are used to produce two dimensional images of the structures using high-frequency sound waves.

B/W ultrasound systems and Color Doppler ultrasound systems have been tracked under this taxonomy. Tracked hereunder are

the equipments only and not accessories and/or additional costs associated with ultrasound system installation.

Black and White (B/W) Ultrasound Systems

Black and White (B/W) ultrasound system is used in the visualization of internal organs and obtains images in shades of grey.

Primary application for B/W ultrasound system lies in gynecology, liver disorders, cardiology etc. Portable and stand-alone B/W

ultrasound systems have been tracked.

Portable B/W Ultrasound Systems

Portable B/W Ultrasound Systems include hand held systems which come in size similar to tablets and lap tops. One unit is

defined as one portable B/W ultrasound system.

Stand Alone B/W Ultrasound Systems

Stand Alone B/W Ultrasound Systems include cart based or trolley based systems. One unit is defined as one stand alone B/W

ultrasound system.

Color Ultrasound Systems

Color Ultrasound System produces a picture of a blood vessel. In addition, a computer converts the doppler sounds into colors that

are overlaid on the image of the blood vessel and that represent the speed and direction of blood flow through the vessel. Color

ultrasound employs the 'Doppler effect' principle to visualize moving objects and blood flow and has primary application in

cardiology and gynecology. Hereunder, Portable and Stand Alone Color Ultrasound Systems have been tracked.

Portable Color Ultrasound Systems

Portable Color Ultrasound Systems include hand held systems which come in size similar to tablets and lap tops. One unit is

defined as one portable color ultrasound system.

Stand Alone Color Ultrasound Systems

Stand Alone Color Ultrasound Systems include cart based or trolley based systems. One unit is defined as one stand alone color

ultrasound system.



X-ray Systems

X-Ray Systems use high-energy radiations to diagnose diseases by taking images of internal structure of body. Analog X-ray

systems and Digital X-Ray systems are included under this category. Tracked hereunder are the equipments only and not

accessories and/or additional costs associated with X-ray system installation.

Analog X-ray Systems

The analog X-ray systems are devices that are used to obtain diagnostic images of the internal structures of the body in the form

of thin films. Revenues generated through sales of X-ray films have not been tracked. One unit is defined as one analog X-ray

system.

Digital X-ray Systems

Digital X-ray systems incorporate digital radiography and obtain images on a screen rather than a film. These include Computed

Radiography & Digital Radiography systems. The dental X-ray systems have been tracked under dental devices market separately

and are not considered here.

Computed Radiography (CR) Systems

Computed radiography involves an indirect diagnostic imaging system. The receptor used within a CR cassette absorbs the

radiation exiting the patient. The absorbed energy is then extracted by processing the exposed plate in a CR reader. Before

viewing the images, the stored information in the CR imaging plate is processed. A digital image is generated by converting the

analog signal from the resultant latent image data to a digital signal. A CR system includes X-ray tube, CR reader, CR cassette

and operating console. One unit is defined as one CR system.

Digital Radiography (DR) Systems

Direct or Digital Radiography (DR) is a form of x-ray imaging, where digital x-ray sensors are used instead of traditional

photographic film. The image brightness and contrast can be modified by digital processing of the acquired image data. Digital

imaging systems can produce adequate image contrast over a much broader range of exposure levels than film-screen imaging

systems. A Digital Radiography system includes x-ray tube, upright stand/patient table, detector plate and operating console. One

unit is defined as one DR system.

Retrofit X-ray Systems

Retrofit X-ray systems are digital panel detectors that enable the upgrade of analog X-ray systems to Digital. One unit consists of

one retrofit X-ray system.



3 Diagnostic Imaging Market, Russia

3.1 Diagnostic Imaging Market, Russia, Revenue ($m), 2005-2020

Figure 1: Diagnostic Imaging Market, Russia, Revenue ($m), USD Constant, 2005-2020

Source: GlobalData



Table 1: Diagnostic Imaging Market, Russia, Revenue ($m), USD Constant, 2005-2020

Category 2005 2012 2020 CAGR 05-12 CAGR 12-20 CAGR 05-20

Source: GlobalData



3.2 Diagnostic Imaging Market, Russia, Revenue Mix ($m), 2012

Figure 2: Diagnostic Imaging Market, Russia, Revenue Mix ($m), 2012

Source: GlobalData



3.3 Diagnostic Imaging Market, Russia, Category Contribution by Revenue ($m), 2012

Figure 3: Diagnostic Imaging Market, Russia, Category Contribution (%), 2012

Source: GlobalData



Table 2: Diagnostic Imaging Market, Russia, Category Contribution by Revenue ($m), 2012

Category Revenue ($m) Contribution Revenue (%) Contribution

Source: GlobalData



Page 169

18 Appendix

The data and analysis within this report are driven by Medical eTrack. Medical eTrack gives you the key information

required to drive sales, investment and deal-making activity in your business. It includes the following:

15,000+ data tables showing market size across more than 780 medical equipment segments and 15 countries,

from 2005 and forecast to 2020

6,000+ primary expert interviews, conducted annually to ensure data and report quality

1,100+ medical equipment conference reports

1,000+ industry-leading reports per annum, covering growing sectors, market trends, investment opportunities

and competitive landscape

600+ analysis reports, covering market and pipeline product analysis, by indication; medical equipment trends

and issues, and investment and M&A trends worth over $3m

50,000+ medical equipment company profiles

2,000+ private, emerging and technology start-up company profiles

4,000+ company profiles of medical equipment manufacturers in China and India

2,000+ company profiles of medical equipment manufacturers in Japan

825+ companies’ revenue splits and market shares

1,100+ quarterly and annual medical equipment company financials

700+ medical equipment company SWOTs

11,700+ pipeline product profiles

14,000+ marketed product profiles

16,900+ clinical trials

17,000+ trial investigators

18,000+ new product patents

3,700+ reports on companies with products in development

21,500+ reports on deals in the medical equipment industry

1,300+ surgical and diagnostic procedures by therapy area

50+ key healthcare indicators by country

For more information or to receive a free demonstration of the service, please visit:

http://www.medicaletrack.com/ContactUs.aspx?Id=RequestDemo



Page 170

18.1 Research Methodology

GlobalData’s dedicated research and analysis teams consist of experienced professionals with advanced statistical

expertise and marketing, market research and consulting backgrounds in the medical devices industry.

GlobalData adheres to the codes of practice of the European Pharmaceutical Marketing Research Association

(http://www.ephmra.org/).

All GlobalData databases are continuously updated and revised.

18.1.1 Coverage

The objective of updating GlobalData’s coverage is to ensure that it represents the most up-to-date vision of the

industry possible.

Changes to the industry taxonomy are built on the basis of extensive research of company, association and

competitor sources.

Company coverage is based on three key factors: revenue; product and media attention; and innovation and market

potential.

The estimated revenue of all major companies, both private and public, are gathered and used to prioritize coverage.

GlobalData aims to cover all major news events and deals in the medical devices industry, updated on a daily basis.

The coverage is further streamlined and strengthened with additional input from GlobalData’s expert panel.

18.1.2 Secondary Research

The research process begins with extensive secondary research using internal and external sources to gather all

relevant data and information pertaining to a particular market model for a particular country. The secondary research

sources that are typically referred to include, but are not limited to:

Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings

Industry trade journals, scientific journals and other technical literature

Association and healthcare organization websites

PubMed, Medscape and other relevant services which compile extensive reviews of clinical literature

Internal proprietary databases

Relevant patent and regulatory databases

National government documents, statistical databases and market reports

Procedure registries

News articles, press releases and web-casts specific to the companies operating in the market



Page 171

18.1.3 Primary Research

GlobalData conducts interviews with industry participants and commentators in order to validate its data and analysis.

A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape and

future outlook

Helps to validate and strengthen secondary research findings

Further develops the analysis team’s expertise and market understanding

Primary research involves email correspondence, telephone interviews and face-to-face interviews for each market,

category, segment and sub-segment across a range of geographies.

The participants who typically take part in such a process include, but are not limited to:

o Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and

national sales managers

o Distributors, paramedics and representatives from hospital stores, laboratories and pharmacies

o Outside experts: investment bankers, valuation experts and research analysts that specialize in specific

medical equipment markets

o Key opinion leaders: physicians and surgeons that specialize in the therapeutic areas in which the

medical device is used

The following table lists the total number of primary research participants by country, in this case for the diagnostic

imaging equipment market. Market data is validated using inputs from 895 primary research participants. These

include demand-side stakeholders such as radiologists, and supply-side participants such as marketing managers,

sales managers and product managers of companies manufacturing/marketing diagnostic imaging equipment.



Page 172

Table 96: Total Number of Primary Research Participants, Diagnostic Imaging Equipment Market, by Country

Country Total number of primary research participants

US 149

UK 112

Germany 79

France 54

Italy 40

Spain 53

Brazil 30

China 21

India 76

Russia 33

Japan 31

Australia 61

Canada 71

Mexico 43

South Korea 42

Total 895

Source: GlobalData

18.1.4 Market Modeling and Forecasting

GlobalData uses an epidemiology-based treatment flow model and capital equipment-based model to estimate and

forecast market size.

Epidemiology-Based Market Model and Forecasting

The epidemiology-based forecasting model uses epidemiology data gathered from research publications and primary

interviews with physicians to establish the target patient population and treatment flow pattern for individual diseases

and therapies. The data covers prevalence, incidence, diseased population, diagnosed population, and treatment

population.

The market forecast begins with the general population, the size of which varies depending on the indication.

Prevalence is the percentage of the total population that suffers from a particular disease or condition.

Incidence is the number of new cases of a condition, symptom, death or injury that develop during a specific

time period, such as one year.

The diseased population is the population suffering from a particular disease or condition.

The diagnosed population is the population that has been diagnosed with a particular disease or condition,

expressed as a percentage of the prevalence population.

The treatment population is the percentage of the population that has been diagnosed with a particular

disease or condition.



Page 173

Device uptake is the percentage of the treatment population using a particular device, determined based on

the primary responses and the information available in secondary sources.

The epidemiology-based forecasting model for a medical device is used to:

Determine the patient segment using a particular device or procedure

Determine the frequency of usage of a particular device depending on the patient type, which further helps to

determine the absolute unit sales of a device in a year

The market for any medical device is directly proportional to the volume of units sold and the price per unit.

Market size = volumes of units sold X ASP (Average Selling Price)

The volume of units sold is calculated from the number of patients using or that has been implanted with the device.

Data on treatment rate, diagnosis and surgical treatment rate, if unavailable from research publications, is gathered

from interviews with physicians and used to estimate the patient volume for the disease under consideration.

The ASP of a device is mostly gathered from primary and secondary sources. ASP is the price at which a device is

available in a target country to an end-user. For capital equipment, the end-user is typically considered to be the

healthcare setting. For implants and consumables purchased by patients, the end-user is the patient.

Factors such as company share, reimbursement, company type (local/domestic or multinational) are taken into

consideration during ASP analysis, which uses the following sources:

Company websites

Annual reports/industry reports

Press releases



Page 174

Epidemiology-Based Forecasting Model

Capital Equipment-Based Market Model and Forecasting

The capital equipment-based forecasting model is based on the installed base, replacements and new sales of a

specific type of capital equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. The

installed base is calculated from the average number of units per facility. Sales for a particular year are arrived at by

calculating the number of replacement units and new units (additional and first-time purchases). Secondary sources

and interviews with supply-side participants and key opinion leaders from healthcare facilities are used to arrive at

installed base and unit sales for a particular year. The factors typically affecting the forecast growth rates are:

Growth in the number of healthcare facilities

Healthcare spending and government programs and initiatives

Migration from low-end equipment to high-end equipment

Growth in the diagnosed population and treatment population

Figure 69: GlobalData Epidemiology-Based Forecasting Model

Source: GlobalData



Page 175

Capital Equipment-Based Forecasting Model

18.1.5 Company Share Analysis

Company shares are calculated by analyzing a company’s sales in a particular market. In the case of public

companies, annual reports and regulatory filings, investor presentations, earnings call transcripts and broker reports

are used to determine a company’s revenue in a particular market and in a particular geography.

In the case of the private companies, company share data is gathered mostly from primary interviews and secondary

sources. Company share analysis is based on primary interviews with:

Supply side (manufacturers)

Procurement side

Distributors

Hospital purchasing groups

Demand side (surgeons/specialists)

Figure 70: GlobalData Capital Equipment-Based Forecasting Model

Source: GlobalData



Page 176

The benefits of this approach are:

High number of respondents to validate and from which to derive accurate company shares

Broad view from the supply, demand, and procurement side

Prevents biased opinions being reproduced

Demand-side interviews with key opinion leaders help to understand their preferences for the devices of

specific companies, strengthening company share estimates

Primary Interviews by Participant Type

Figure 71: Primary Interviews by Participant Type (%)

The final company share data is based on input from the supply side, the procurement side and the demand side, as

well as secondary sources.

18.1.6 Distribution Share Analysis

Distribution share information is gathered using a combination of secondary and primary research. It is supported by

primary interviews because the availability of secondary data is limited in most cases.

18.2 Expert Panel

GlobalData uses a panel of experts to cross-verify its databases and forecasts.

GlobalData’s expert panel comprises marketing managers, product specialists, international sales managers from

medical device companies, academics from research universities, key opinion leaders from hospitals, consultants

from venture capital funds and distributors/suppliers of medical equipment and supplies.

Historic data and forecasts are relayed to GlobalData’s expert panel for feedback and adjusted accordingly.

50

25

25

Procurement side Supply side Demand side



Page 177

18.3 GlobalData Consulting

We hope that the data and analysis in this brief will help you to make informed and imaginative business decisions. If

you have further requirements, GlobalData’s consulting team may be able to help you. GlobalData offers tailor-made

analytical and advisory services to drive your key strategic decisions.

18.4 Disclaimer

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means,

electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher,

GlobalData.

russia diagnostic imaging market outlook to 2020 · russia diagnostic imaging market outlook to...

Documents